Clinical Trial Update: One Year Study to Evaluate the Safety of the Combination of Valsartan and Amlodipine in Patients With Hypertension [Phase 3]

View source ↗

Summary

Phase 3 trial assessing the safety of the valsartan and amlodipine combination in hypertension has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypertension

Drugs mentioned

• Amlodipine (amlodipine)
• VALSARTAN (Valsartan)

Snippet

Sponsor: Novartis | Conditions: Hypertension | Phase 3 | Status: COMPLETED